BridgeBio Oncology Therapeutics (BBOT) Interest Income - Total (2024 - 2026)
BridgeBio Oncology Therapeutics (BBOT) posted Interest Income - Total of $3.9 million for Q1 2026, down 10.85% sequentially from $4.4 million in Q4 2025, and up 118.02% YoY from $1.8 million in Q1 2025.
BridgeBio Oncology Therapeutics (BBOT) Interest Income - Total (2024 - 2026) Analysis & Trends
BridgeBio Oncology Therapeutics has reported Interest Income - Total for 3 years, with the latest figure at $3.9 million in Q1 2026.
- Quarterly Interest Income - Total rose 118.02% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (changed N/A YoY) and the FY2025 annual result came in at $11.3 million, up 77.87% from the prior year.
- Interest Income - Total declined to $3.9 million in Q1 2026 per BBOT's latest filing, from $4.4 million in the prior quarter.
- Over five years, Interest Income - Total peaked at $4.4 million in Q4 2025 and troughed at $1.8 million in Q1 2025.
- A 3-year average of $3.0 million and a median of $3.0 million in 2024 frame the typical range for Interest Income - Total.
- The sharpest annual moves came in 2025 and 2026: Interest Income - Total soared 39.26% in 2025, then jumped 118.02% in 2026.
- Over 3 years, Interest Income - Total stood at $2.1 million in 2024, then surged by 107.41% to $4.4 million in 2025, then fell by 10.85% to $3.9 million in 2026.
- According to Business Quant data, Interest Income - Total over the past three periods registered $3.9 million, $4.4 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | BridgeBio Oncology Therapeutics | 726.38 Mn | 500.67 Mn | - | 3.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.55 Mn |
| Jun 30, 2026 | 3.55 Mn |
| Mar 31, 2026 | 3.94 Mn |
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 4.42 Mn |
| Dec 31, 2025 | 4.42 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.47 Mn |
| Sep 30, 2024 | 2.47 Mn |